Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
Two new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosize...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI |
_version_ | 1811160131910500352 |
---|---|
author | Ghaidaa H. Alfaifi Thoraya A. Farghaly Magda H. Abdellattif |
author_facet | Ghaidaa H. Alfaifi Thoraya A. Farghaly Magda H. Abdellattif |
author_sort | Ghaidaa H. Alfaifi |
collection | DOAJ |
description | Two new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosized scale. The two series were tested for their efficacy and toxicity as anti-colon and stomach cancers. Derivative 10d showed activity more than the two reference drugs used in the case of SNU-16. Surpislly, in the case of COLO205, five derivatives 4, 6c, 6d, 6e, and 10a are better than the two benchmarks used, and two derivatives, 14a and 14b more potent than cisplatin. All potent derivatives showed a strong fit with the active site of the two tested proteins (gastric cancer (PDB = 2BID) and colon cancer (PDB = 2A4L)) in the molecular docking study. The Pharmacophore and ADME studies of the new derivatives showed that most derivatives revealed promising bioactivity, which indicates the drug-likeness properties against kinase inhibitors, protease, and enzyme inhibitors. In addition, the ProTox-II showed that the four compounds 10d, 16, 6d, and 10a are predicted to have oral LD50 values ranging from 335 to 3500 mg/kg in a rat model with (1 s,4 s)-Eucalyptol bearing the highest values and quercetin holding the lowest one. |
first_indexed | 2024-04-10T05:52:50Z |
format | Article |
id | doaj.art-5a6388686c6d4e1d85e19bc0b814d602 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-10T05:52:50Z |
publishDate | 2023-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-5a6388686c6d4e1d85e19bc0b814d6022023-03-04T05:31:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration propertiesGhaidaa H. AlfaifiThoraya A. FarghalyMagda H. AbdellattifTwo new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosized scale. The two series were tested for their efficacy and toxicity as anti-colon and stomach cancers. Derivative 10d showed activity more than the two reference drugs used in the case of SNU-16. Surpislly, in the case of COLO205, five derivatives 4, 6c, 6d, 6e, and 10a are better than the two benchmarks used, and two derivatives, 14a and 14b more potent than cisplatin. All potent derivatives showed a strong fit with the active site of the two tested proteins (gastric cancer (PDB = 2BID) and colon cancer (PDB = 2A4L)) in the molecular docking study. The Pharmacophore and ADME studies of the new derivatives showed that most derivatives revealed promising bioactivity, which indicates the drug-likeness properties against kinase inhibitors, protease, and enzyme inhibitors. In addition, the ProTox-II showed that the four compounds 10d, 16, 6d, and 10a are predicted to have oral LD50 values ranging from 335 to 3500 mg/kg in a rat model with (1 s,4 s)-Eucalyptol bearing the highest values and quercetin holding the lowest one.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI |
spellingShingle | Ghaidaa H. Alfaifi Thoraya A. Farghaly Magda H. Abdellattif Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties PLoS ONE |
title | Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties |
title_full | Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties |
title_fullStr | Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties |
title_full_unstemmed | Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties |
title_short | Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties |
title_sort | indenyl thiazole and indenyl formazan derivatives synthesis anticancer screening studies molecular docking and pharmacokinetic molin spiration properties |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI |
work_keys_str_mv | AT ghaidaahalfaifi indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties AT thorayaafarghaly indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties AT magdahabdellattif indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties |